Milestone Scientific elected to convert remaining amounts of amended convertible bridge notes into common stock once fair value reaches $0.50 and insiders clear trading compliance.

Key Highlights:

  • Three directors submitted conversion notices to convert remaining principal and accrued interest of their Convertible Bridge Notes into common stock.
  • Remaining outstanding principal per holder: $116,495.47 (Casamento), $58,247.73 (Demesmin), $291,238.66 (Goldman).
  • Conversions will automatically occur when the Fair Value of common stock is at least $0.50 per share and insider trading pre-clearance is satisfied.
  • No shares have been issued under these Conversion Notices as of the filing date.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.